PB2259: THE NEW PD-1 INHIBITOR PROLGOLIMAB IN THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN’S LYMPHOMA

• Anastasia Semenova,
• Shpirko Valeria,
• Gayane Tumyan,
• Arman Arakelyan,
• Timur Valiev,
• Sergei Lepkov,
• Galina Petrova,
• Elena Demina,
• Evgenia Paramonova,
• Daria Tupitsyna,
• Julia Kluchagina,
• Danila Lifentsev,
• Dzhelil Shevketovich

Affiliations

Anastasia Semenova

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia

Shpirko Valeria

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia

Gayane Tumyan

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia

Arman Arakelyan

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia

Timur Valiev

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia

Sergei Lepkov

3 Pirogov Russian National Research Medical University, Moscow, Russia

Galina Petrova

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia

Elena Demina

4 National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russia

Evgenia Paramonova

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia

Daria Tupitsyna

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia

Julia Kluchagina

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia

Danila Lifentsev

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia

Dzhelil Shevketovich

1 N.N. Blokhin Cancer Research Center, Hematology Department, Moscow, Russia